FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacques Grosset

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Physiology

Microbial Drug Resistance

Anatomy

Lung

Co-author Network

Publications

TOP 3
Fred Stephen Sarfo; Mark Wansbrough-Jones; Jihui Zhang; Deepak V Almeida; Paul J Converse; Clive Robinson; Jacques H Grosset
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
Claire Andréjak; Paul J Converse; Deepak V Almeida; Nicole C Ammerman; Sandeep Tyagi; Jacques H Grosset
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
Eric Nuermberger; Charles A Peloquin; Ian M Rosenthal; Rokeya Tasneen; Petros C Karakousis; Khisimuzi E Mdluli; Jacques H Grosset
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacques Grosset (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fred Stephen Sarfo; Mark Wansbrough-Jones; Jihui Zhang; Deepak V Almeida; Paul J Converse; Clive Robinson; Jacques H Grosset
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
PLoS neglected tropical diseases 2013;7(3):e2101.
2013: Claire Andréjak; Paul J Converse; Deepak V Almeida; Nicole C Ammerman; Sandeep Tyagi; Jacques H Grosset
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
The Journal of antimicrobial chemotherapy 2013;68(3):659-65.
2013: Eric Nuermberger; Charles A Peloquin; Ian M Rosenthal; Rokeya Tasneen; Petros C Karakousis; Khisimuzi E Mdluli; Jacques H Grosset
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".
Antimicrobial agents and chemotherapy 2013;57(2):1104-5.
2013: Deepak V Almeida; Paul J Converse; Si-Yang Li; Eric Nuermberger; Sandeep Tyagi; Jacques H Grosset
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
PLoS neglected tropical diseases 2013;7(2):e2085.
2012: Zahoor Ahmad; Deepak Almeida; Anthony S Baughn; Williams R Jacobs; Austin Minkowsk; Eric Nuermberger; Kaitlin M Peck; Sandeep Tyagi; John T Welch; Jacques H Grosset
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
The Indian journal of medical research 2012;136(5):808-14.
2012: Jacques H Grosset; Richard Hafner; Umesh Lalloo; Si-Yang Li; Alexander S Pym; Susan Swindells; Sandeep Tyagi; Kristina Wallengren; Deepak Almeida; Nicole C Ammerman; Paul J Converse; William R Bishai
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(37):15001-5.
2012: Jacques H Grosset; T G Singer; William R Bishai
New drugs for the treatment of tuberculosis: hope and reality.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012;16(8):1005-14.
2012: Ian M Rosenthal; Rokeya Tasneen; Ming Zhang; Charles A Peloquin; Deepak Almeida; Jacques H Grosset; Petros C Karakousis; Khisimuzi E Mdluli; Eric Nuermberger
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Antimicrobial agents and chemotherapy 2012;56(8):4331-40.
2012: Noton Kumar Dutta; Jacques H Grosset; PETER ILLEI; Khisimuzi E Mdluli; Eric Nuermberger; Charles A Peloquin; Michael L Pinn; Petros C Karakousis
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Antimicrobial agents and chemotherapy 2012;56(7):3726-31.
2011: Kwok Chiu Chang; Jacques H Grosset; Chi Chiu Leung; Wing Wai Yew
Treatment of tuberculosis and optimal dosing schedules.
Thorax 2011;66(11):997-1007.
2011: Paul J Converse; Deepak V Almeida; Eric Nuermberger; Jacques H Grosset
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
Future microbiology 2011;6(10):1185-98.
2011: Zahoor Ahmad; Mostafa M Fraig; Jacques H Grosset; Eric Nuermberger; Michael L Pinn; Sandeep Tyagi; Petros C Karakousis
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
The Journal of antimicrobial chemotherapy 2011;66(7):1560-6.
2011: Ming Zhang; Si-Yang Li; Ian M Rosenthal; Deepak V Almeida; Zahoor Ahmad; Paul J Converse; Charles A Peloquin; Eric Nuermberger; Jacques H Grosset
Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
American journal of respiratory and critical care medicine 2011;183(9):1254-61.
2011: Chi Chiu Leung; Wing Wai Yew; Jacques H Grosset
Harnessing the full sterilising activity of rifamycins.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2011;15(4):429-30.
2011: Zahoor Ahmad; Mostafa M Fraig; Gregory P Bisson; Eric Nuermberger; Jacques H Grosset; Petros C Karakousis
Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
Antimicrobial agents and chemotherapy 2011;55(4):1527-32.
2011: Zahoor Ahmad; Austin Minkowski; Charles A Peloquin; Kathy N Williams; Khisimuzi E Mdluli; Jacques H Grosset; Eric Nuermberger
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(4):1781-3.
2011: Francesca Sánchez; José L López-Colomés; Elsa Villarino; Jacques H Grosset
New drugs for tuberculosis treatment.
Enfermedades infecciosas y microbiología clínica 2011;29 Suppl 1():47-56.
2011: Paul J Converse; Deepak V Almeida; Eric Nuermberger; Jacques H Grosset
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
PLoS neglected tropical diseases 2011;5(3):e985.
2011: Deepak Almeida; Paul J Converse; Zahoor Ahmad; Kelly E Dooley; Eric Nuermberger; Jacques H Grosset
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
PLoS neglected tropical diseases 2011;5(1):e933.
2011: Tianyu Zhang; Si-Yang Li; Paul J Converse; Deepak V Almeida; Jacques H Grosset; Eric Nuermberger
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
Antimicrobial agents and chemotherapy 2011;55(1):56-61.
2011: Zahoor Ahmad; Charles A Peloquin; Rajendra P Singh; Hartmut Derendorf; Sandeep Tyagi; Ann Ginsberg; Jacques H Grosset; Eric Nuermberger
PA-824 exhibits time-dependent activity in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(1):239-45.
2010: Zahoor Ahmad; Michael L Pinn; Eric Nuermberger; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
The Journal of antimicrobial chemotherapy 2010;65(10):2172-5.
2010: J W C Alffenaar; W A Nienhuis; F de Velde; A T Zuur; A M A Wessels; D Almeida; Jacques H Grosset; O Adjei; D R A Uges; T S van der Werf
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.
Antimicrobial agents and chemotherapy 2010;54(9):3878-83.
2010: Tianyu Zhang; William R Bishai; Jacques H Grosset; Eric Nuermberger
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Antimicrobial agents and chemotherapy 2010;54(7):2806-13.
2010: Zahoor Ahmad; Eric Nuermberger; Rokeya Tasneen; Michael L Pinn; Kathy N Williams; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
The Journal of antimicrobial chemotherapy 2010;65(4):729-34.
2010: Omonike Olaleye; Tirumalai R Raghunand; Shridhar Bhat; Jian He; Sandeep Tyagi; Gyanu Lamichhane; Peihua Gu; Jiangbing Zhou; Ying Zhang; Jacques H Grosset; William R Bishai; Jun O Liu
Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets.
Chemistry & biology 2010;17(1):86-97.
2010: Paul J Converse; Kathleen D Eisenach; Sue A Theus; Eric Nuermberger; Sandeep Tyagi; Lan H Ly; Deborah E Geiman; Haidan Guo; Scott Nolan; Nicole C Akar; Lee G Klinkenberg; Radhika Gupta; Shichun Lun; Petros C Karakousis; Gyanu Lamichhane; David N McMurray; Jacques H Grosset; William R Bishai
The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.
PloS one 2010;5(4):e10289.
2009: Tianyu Zhang; Ming Zhang; Ian M Rosenthal; Jacques H Grosset; Eric Nuermberger
Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.
American journal of respiratory and critical care medicine 2009;180(11):1151-7.
2009: Zahoor Ahmad; Lee G Klinkenberg; Michael L Pinn; Mostafa M Fraig; Charles A Peloquin; William R Bishai; Eric Nuermberger; Jacques H Grosset; Petros C Karakousis
Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
The Journal of infectious diseases 2009;200(7):1136-43.
2009: Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques H Grosset
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
Antimicrobial agents and chemotherapy 2009;53(10):4178-84.
2009: Kathy N Williams; Steven J Brickner; C Kendall Stover; Tong Zhu; Adam Ogden; Rokeya Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
American journal of respiratory and critical care medicine 2009;180(4):371-6.
2009: Susan E Dorman; John L Johnson; Stefan Goldberg; Grace Muzanye; Nesri Padayatchi; Lorna Bozeman; Charles M Heilig; John Bernardo; Shurjeel Choudhri; Jacques H Grosset; Elizabeth Guy; Priya Guyadeen; Maria Corazon Leus; Gina Maltas; Dick Menzies; Eric Nuermberger; Margarita Villarino; Andrew Vernon; Richard E Chaisson
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
American journal of respiratory and critical care medicine 2009;180(3):273-80.
2009: Vadim Makarov; Giulia Manina; Katarina Mikusova; Ute Möllmann; Olga Ryabova; Brigitte Saint-Joanis; Neeraj Dhar; Maria Rosalia Pasca; Silvia Buroni; Anna Paola Lucarelli; Anna Milano; Edda De Rossi; Martina Belanova; Adela Bobovska; Petronela Dianiskova; Jana Kordulakova; Claudia Sala; Elizabeth Fullam; Patricia Schneider; John D McKinney; Priscille Brodin; Thierry Christophe; Simon Waddell; Philip Butcher; Jakob Albrethsen; Ida Rosenkrands; Roland Brosch; Vrinda Nandi; Sowmya Bharath; Sheshagiri Gaonkar; Radha K Shandil; Venkataraman Balasubramanian; Tanjore Balganesh; Sandeep Tyagi; Jacques H Grosset; Giovanna Riccardi; Stewart T Cole
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Science (New York, N.Y.) 2009;324(5928):801-4.
2009: Kathy N Williams; C Kendall Stover; T Zhu; R Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Antimicrobial agents and chemotherapy 2009;53(4):1314-9.
2009: Paul J Converse; Petros C Karakousis; Lee G Klinkenberg; Anup Kesavan; Lan H Ly; Shannon Sedberry Allen; Jacques H Grosset; Sanjay K Jain; Gyanu Lamichhane; Yukari C Manabe; David N McMurray; Eric Nuermberger; William R Bishai
Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
Infection and immunity 2009;77(3):1230-7.
2008: Nicholas A Be; Gyanu Lamichhane; Jacques H Grosset; Sandeep Tyagi; Qi-Jian Cheng; Kwang S Kim; William R Bishai; Sanjay K Jain
Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system.
The Journal of infectious diseases 2008;198(10):1520-8.
2008: Ian M Rosenthal; Ming Zhang; Deepak Almeida; Jacques H Grosset; Eric Nuermberger
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
American journal of respiratory and critical care medicine 2008;178(9):989-93.
2008: Rokeya Tasneen; Sandeep Tyagi; Kathy Williams; Jacques H Grosset; Eric Nuermberger
Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(10):3664-8.
2008: Eric Nuermberger; Sandeep Tyagi; Rokeya Tasneen; Kathy N Williams; Deepak Almeida; Ian M Rosenthal; Jacques H Grosset
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(4):1522-4.
2007: Ian M Rosenthal; Ming Zhang; Kathy N Williams; Charles A Peloquin; Sandeep Tyagi; Andrew Vernon; William R Bishai; Richard E Chaisson; Jacques H Grosset; Eric Nuermberger
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
PLoS medicine 2007;4(12):e344.
2007: Deepak Almeida; Eric Nuermberger; Sandeep Tyagi; William R Bishai; Jacques H Grosset
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2007;51(12):4261-6.
2007: Annick Chauty; Marie-Françoise Ardant; Ambroise Adeye; Hélène Euverte; Augustin Guédénon; Christian Johnson; Jacques Aubry; Eric Nuermberger; Jacques H Grosset
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Antimicrobial agents and chemotherapy 2007;51(11):4029-35.
2007: Sanjay K Jain; S Moises Hernandez-Abanto; Qi-Jian Cheng; Prabhpreet Singh; Lan H Ly; Lee G Klinkenberg; Norman E Morrison; Paul J Converse; Eric Nuermberger; Jacques H Grosset; David N McMurray; Petros C Karakousis; Gyanu Lamichhane; William R Bishai
Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice.
The Journal of infectious diseases 2007;195(11):1634-42.
2007: Geraint R Davies; A S Pym; Denis A Mitchison; Eric Nuermberger; Jacques H Grosset
Evaluation of new antituberculosis drugs in mouse models.
Antimicrobial agents and chemotherapy 2007;51(1):403; author reply 403-4.
2006: Eric Nuermberger; Ian M Rosenthal; Sandeep Tyagi; Kathy N Williams; Deepak Almeida; Charles A Peloquin; William R Bishai; Jacques H Grosset
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2006;50(8):2621-5.
2006: Ian M Rosenthal; Kathy Williams; Sandeep Tyagi; Charles A Peloquin; Andrew Vernon; William R Bishai; Jacques H Grosset; Eric Nuermberger
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
American journal of respiratory and critical care medicine 2006;174(1):94-101.
2005: J Maugein; M Dailloux; B Carbonnelle; V Vincent; Jacques H Grosset
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(6):1092-6.
2005: Eric Nuermberger; Sandeep Tyagi; Kathy N Williams; Ian M Rosenthal; William R Bishai; Jacques H Grosset
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
American journal of respiratory and critical care medicine 2005;172(11):1452-6.
2005: Ian M Rosenthal; Kathy Williams; Sandeep Tyagi; Andrew Vernon; Charles A Peloquin; William R Bishai; Jacques H Grosset; Eric Nuermberger
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
American journal of respiratory and critical care medicine 2005;172(11):1457-62.
2005: Amy Sarah Ginsburg; Ronggai Sun; Heather Calamita; Cherise P Scott; William R Bishai; Jacques H Grosset
Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model.
Antimicrobial agents and chemotherapy 2005;49(9):3977-9.
2005: Samuel Etuaful; B Carbonnelle; Jacques H Grosset; Sebastian Lucas; Catherine Horsfield; Richard Phillips; M Evans; David Ofori-Adjei; E Klustse; J Owusu-Boateng; Geoffrey K Amedofu; Peter Awuah; Edwin O Ampadu; George Amofah; Kingsley Asiedu; Mark Wansbrough-Jones
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
Antimicrobial agents and chemotherapy 2005;49(8):3182-6.
2005: Sandeep Tyagi; Eric Nuermberger; Tetsuyuki Yoshimatsu; Kathy Williams; Ian M Rosenthal; Nacer Lounis; William R Bishai; Jacques H Grosset
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2005;49(6):2289-93.
2005: Amy Sarah Ginsburg; Jin Lee; Samuel C Woolwine; Jacques H Grosset; Fayez M Hamzeh; William R Bishai
Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.
Antimicrobial agents and chemotherapy 2005;49(2):853-6.
2005: Manuel Casal; M Vaquero; H Rinder; ENRICO TORTOLI; Jacques H Grosset; S Rüsch-Gerdes; J Gutiérrez; V Jarlier
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries.
Microbial drug resistance (Larchmont, N.Y.) 2005;11(1):62-7.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; Kathy Williams; Ian M Rosenthal; Richard J O'Brien; Andrew Vernon; Richard E Chaisson; William R Bishai; Jacques H Grosset
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;170(10):1131-4.
2004: Petros C Karakousis; Tetsuyuki Yoshimatsu; Gyanu Lamichhane; Samuel C Woolwine; Eric Nuermberger; Jacques H Grosset; William R Bishai
Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.
The Journal of experimental medicine 2004;200(5):647-57.
2004: Eric Nuermberger; William R Bishai; Jacques H Grosset
Latent tuberculosis infection.
Seminars in respiratory and critical care medicine 2004;25(3):317-36.
2004: Eric Nuermberger; Jacques H Grosset
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(4):243-55.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; William R Bishai; Jacques H Grosset
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
Infection and immunity 2004;72(2):1065-71.
2004: Eric Nuermberger; Tetsuyuki Yoshimatsu; Sandeep Tyagi; Richard J O'Brien; Andrew N Vernon; Richard E Chaisson; William R Bishai; Jacques H Grosset
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;169(3):421-6.
2003: Hoang Thi Quy; N T N Lan; Martien Borgdorff; Jacques H Grosset; P D Linh; LB Tung; Dick Van Soolingen; Mario C Raviglione; N V Cô; Jaap Broekmans
Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(7):631-6.
2003: Amy Sarah Ginsburg; Jacques H Grosset; William R Bishai
Fluoroquinolones, tuberculosis, and resistance.
The Lancet infectious diseases 2003;3(7):432-42.
2003: Gyanu Lamichhane; Matteo Zignol; NATALIE BLADES; Deborah E Geiman; Annette Dougherty; Jacques H Grosset; Karl W Broman; William R Bishai
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7213-8.
2003: Nacer Lounis; C Maslo; Chantal Truffot-Pernot; Jacques H Grosset; R J Boelaert
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(6):575-9.
2003: X Emmanuelli; Jacques H Grosset
[Tuberculosis and poverty].
Revue des maladies respiratoires 2003;20(2 Pt 1):169-71.
2003: Jacques H Grosset
Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.
Antimicrobial agents and chemotherapy 2003;47(3):833-6.
2002: Herve Dega; Abdelhalim Bentoucha; Jérôme Robert; Vincent Jarlier; Jacques H Grosset
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Antimicrobial agents and chemotherapy 2002;46(10):3193-6.
2002: Tetsuyuki Yoshimatsu; Eric Nuermberger; Sandeep Tyagi; Richard E Chaisson; William R Bishai; Jacques H Grosset
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
Antimicrobial agents and chemotherapy 2002;46(6):1875-9.
2002: Jacques H Grosset; Laurence Zunic; Christophe Morcrette
[World epidemiology of tuberculosis and resistance against anti-tuberculosis drugs].
Annales de médecine interne 2002;153(2):107-12.
2001: Nadine Honoré; P W Roche; Jacques H Grosset; Stewart T Cole
A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae.
Leprosy review 2001;72(4):441-8.
2001: Jacques H Grosset; S T Cole
Genomics and the chemotherapy of leprosy.
Leprosy review 2001;72(4):429-40.
2001: Nacer Lounis; Abdelhalim Bentoucha; Chantal Truffot-Pernot; Baohong Ji; RJ O'Brien; Andrew Vernon; G Roscigno; Jacques H Grosset
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 2001;45(12):3482-6.
2001: Nacer Lounis; Chantal Truffot-Pernot; Abdelhalim Bentoucha; Jérôme Robert; Baohong Ji; Jacques H Grosset
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
Antimicrobial agents and chemotherapy 2001;45(11):3229-30.
2001: Abdelhalim Bentoucha; Jérôme Robert; Herve Dega; Nacer Lounis; Vincent Jarlier; Jacques H Grosset
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.
Antimicrobial agents and chemotherapy 2001;45(11):3109-12.
2001: Pascal Astagneau; Nicole Desplaces; V Vincent; Valérie Chicheportiche; Anne-Hélène Botherel; Sylvie Maugat; Karine Lebascle; P Léonard; Jean-Claude Desenclos; Jacques H Grosset; Jean-Marc Ziza; Gilles Brücker
Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak.
Lancet 2001;358(9283):747-51.
2001: Jacques H Grosset
Newer drugs in leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 2001;69(2 Suppl):S14-8.
2001: Johan R Boelaert; Rui Appelberg; M Salomé Gomes; Elisabetta Blasi; Rosanna Mazzolla; Jacques H Grosset; Nacer Lounis; Ketty Soteriadou; Maria Thiakaki; Donatella Taramelli; C Tognazioli
Experimental results on chloroquine and AIDS-related opportunistic infections.
Journal of acquired immune deficiency syndromes (1999) 2001;26(3):300-1.
2001: Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset; Victor Roland Gordeuk; Johan R Boelaert
Iron and Mycobacterium tuberculosis infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;20(3):123-6.
2000: Emmanuelle Cambau; Chantal Truffot-Pernot; F Boulahbal; C Wichlacz; Jacques H Grosset; V Jarlier
Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(12):938-42.
2000: B Ji; Jacques H Grosset
Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
Leprosy review 2000;71 Suppl():S81-7.
2000: L N Nguyen; JL Cartel; Jacques H Grosset
Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years.
Leprosy review 2000;71 Suppl():S33-5; discussion S35-6.
2000: Jacques H Grosset
The new challenges for chemotherapy research.
Leprosy review 2000;71 Suppl():S100-4.
2000: S Consigny; Abdelhalim Bentoucha; Pascale Bonnafous; Jacques H Grosset; Baohong Ji
Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
Antimicrobial agents and chemotherapy 2000;44(10):2919-21.
2000: Herve Dega; Olivier Chosidow; Stéphane Barete; B Carbonnelle; Jacques H Grosset; Vincent Jarlier
[Mycobacterium ulcerans infection].
Annales de médecine interne 2000;151(5):339-44.
2000: Herve Dega; Jérôme Robert; Pascale Bonnafous; Vincent Jarlier; Jacques H Grosset
Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.
Antimicrobial agents and chemotherapy 2000;44(9):2367-72.
2000: J Robert; D Trystram; Chantal Truffot-Pernot; B Carbonnelle; Jacques H Grosset
Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(7):665-72.
2000: J Robert; D Trystram; Chantal Truffot-Pernot; Emmanuelle Cambau; Vincent Jarlier; Jacques H Grosset
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(6):504-12.
2000: N Daniel; Nacer Lounis; Baohong Ji; RJ O'Brien; Andrew Vernon; Geiter Lawrence; M Szpytma; Chantal Truffot-Pernot; G Hejblum; Jacques H Grosset
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
American journal of respiratory and critical care medicine 2000;161(5):1572-7.
1999: Baohong Ji; Jacques H Grosset
Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1999;67(4 Suppl):S45-55.
1999: J Robert; F Boulahbal; D Trystram; Chantal Truffot-Pernot; Anne-Claire De Benoist; V Vincent; Vincent Jarlier; Jacques H Grosset
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(8):711-4.
1999: M Flament-Saillour; J Robert; Vincent Jarlier; Jacques H Grosset
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.
American journal of respiratory and critical care medicine 1999;160(2):587-93.
1999: Heinz Rinder; K Feldmann; ENRICO TORTOLI; Jacques H Grosset; M Casal; E Richter; M Rifai; V Jarlier; M Vaquero; S Rüsch-Gerdes; Emmanuelle Cambau; J Gutierrez; Thomas Löscher
Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 1999;4(2):145-52.
1999: Jacques H Grosset
[Which strategies for eradication of tuberculosis?].
Bulletin de l'Académie nationale de médecine 1999;183(7):25-37; discussion 37-40.
1999: Jacques H Grosset
[Leprosy and tuberculosis: opposite results?].
Médecine tropicale : revue du Corps de santé colonial 1999;59(2 Suppl):25-30.
1998: Jacques H Grosset; S Franzblau
Report of workshop on chemotherapy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1998;66(4):595-6.
1998: Anne Carbonne; Nadine Lemaitre; M Bochet; Chantal Truffot-Pernot; C Katlama; Jacques H Grosset; F Bricaire; Vincent Jarlier
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facility.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19(10):784-6.
1998: J C Craft; G F Notario; Jacques H Grosset; LB Heifets
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(4):807-12.
1998: S Jouveshomme; Emmanuelle Cambau; D Trystram; M Szpytma; Wladimir Sougakoff; JP Derenne; Jacques H Grosset
Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis.
American journal of respiratory and critical care medicine 1998;158(4):1096-101.
1998: V Schwoebel; Bénédicte Decludt; Anne-Claire De Benoist; S Haeghebaert; G Torrea; V Vincent; Jacques H Grosset
Multidrug resistant tuberculosis in France 1992-4: two case-control studies.
BMJ (Clinical research ed.) 1998;317(7159):630-1.
1998: Jacques H Grosset
[What's new for tuberculosis in 1998?].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(9):613-6.
1998: Baohong Ji; Nacer Lounis; C Maslo; Chantal Truffot-Pernot; Pascale Bonnafous; Jacques H Grosset
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1998;42(8):2066-9.
1998: N Lemaître; Wladimir Sougakoff; Chantal Truffot-Pernot; Emmanuelle Cambau; J P Derenne; F Bricaire; Jacques H Grosset; Vincent Jarlier
Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1998;2(5):390-6.
1998: Jacques H Grosset; Nacer Lounis; Chantal Truffot-Pernot; RJ O'Brien; M C Raviglione; Baohong Ji
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.
American journal of respiratory and critical care medicine 1998;157(5 Pt 1):1436-40.
1998: Baohong Ji; SO Sow; Evelyne Perani; C Lienhardt; V Diderot; Jacques H Grosset
Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Antimicrobial agents and chemotherapy 1998;42(5):1115-20.
1998: Jacques H Grosset; Chantal Truffot-Pernot
[Mycobacterium xenopi, a newcomer?].
La Revue du praticien 1998;48(7):701-3.
1997: B Wyplosz; Chantal Truffot-Pernot; J Robert; Vincent Jarlier; Jacques H Grosset
[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
Revue des maladies respiratoires 1997;14 Suppl 5():S33-48.
1997: thierry may; F Brel; C Beuscart; Véronique Vincent; C Perronne; T Doco-Lecompte; T Saint-Marc; Bertrand Dautzenberg; Jacques H Grosset
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(3):621-9.
1997: Baohong Ji; P Jamet; SO Sow; Evelyne Perani; I Traore; Jacques H Grosset
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Antimicrobial agents and chemotherapy 1997;41(9):1953-6.
1997: François Gimenez; V Leblond; J Nguyen; P Serrand; J L Binet; Jacques H Grosset; Alain Thuillier
Variations of teicoplanin concentrations in neutropenic patients.
Journal of clinical pharmacy and therapeutics 1997;22(3):187-90.
1997: I Mane; JL Cartel; Jacques H Grosset
Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1997;65(2):224-9.
1997: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
Antimicrobial agents and chemotherapy 1997;41(5):1168-9.
1997: Jacques H Grosset
Whither short-course chemotherapy for leprosy?
Indian journal of leprosy 1997;69(2):119-20.
1997: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?
Antimicrobial agents and chemotherapy 1997;41(3):607-10.
1997: C Iborra; Emmanuelle Cambau; C Lecomte; Jacques H Grosset; François Bricaire; Eric Caumes
[Cutaneous tuberculosis. A study of 4 cases].
Annales de dermatologie et de vénéréologie 1997;124(2):139-43.
1997: Jacques H Grosset; Baohong Ji
Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
Drugs 1997;54 Suppl 2():23-7; discussion 28-9.
1997: Bertrand Dautzenberg; Chantal Truffot-Pernot; J Hazebroucq; S Legris; C Guérin; C Begelman; G Guermonprez; M H Fievet; C Chastang; Jacques H Grosset
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections.
Infection 1997;25(1):16-21.
1996: N Lemaître; Wladimir Sougakoff; D Coëtmeur; J Vaucel; Vincent Jarlier; Jacques H Grosset
Nosocomial transmission of tuberculosis among mentally-handicapped patients in a long-term care facility.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(6):531-6.
1996: Baohong Ji; L Levy; Jacques H Grosset
Chemotherapy of leprosy: progress since the Orlando Congress, and prospects for the future.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1996;64(4 Suppl):S80-8; discussion S88-90.
1996: Baohong Ji; P Jamet; Evelyne Perani; SO Sow; C Lienhardt; C Petinon; Jacques H Grosset
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Antimicrobial agents and chemotherapy 1996;40(9):2137-41.
1996: F Doucet-Populaire; V Lalande; E Carpentier; A Bourgoin; M Dailloux; C Bollet; A Vachée; D Moinard; J Texier-Maugein; B Carbonnelle; Jacques H Grosset
A blind study of the polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA. Azay Mycobacteria Study Group.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(4):358-62.
1996: Jacques H Grosset
[Bacteriological diagnosis of tuberculosis].
La Revue du praticien 1996;46(11):1337-43.
1996: I Traore; Baohong Ji; C Lienhardt; P Bobin; Jacques H Grosset
Determination of the minimal effective dosages of ofloxacin and sparfloxacin against M. leprae in the mouse foot pad system.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1996;64(2):142-5.
1996: Nadine Lemaitre; Wladimir Sougakoff; C Truffot; Jacques H Grosset; Vincent Jarlier
[Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis].
Pathologie-biologie 1996;44(5):452-5.
1996: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Antimicrobial agents and chemotherapy 1996;40(2):437-42.
1996: Baohong Ji; Evelyne Perani; C Petinom; Jacques H Grosset
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Antimicrobial agents and chemotherapy 1996;40(2):393-9.
1996: Jacques H Grosset
Current problems with tuberculosis treatment.
Research in microbiology 1996;147(1-2):10-6.
1995: P Chaulet; F Boulahbal; Jacques H Grosset
Surveillance of drug resistance for tuberculosis control: why and how?
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1995;76(6):487-92.
1995: Chantal Truffot-Pernot; Nacer Lounis; Jacques H Grosset; Baohong Ji
Clarithromycin is inactive against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(12):2827-8.
1995: D A Enarson; Jacques H Grosset; A Mwinga; E S Hershfield; R O'Brien; S Cole; L Reichman
The challenge of tuberculosis: statements on global control and prevention.
Lancet 1995;346(8978):809-19.
1995: L Baril; Eric Caumes; C Truffot-Pernot; François Bricaire; Jacques H Grosset; M Gentilini
Tuberculosis caused by Mycobacterium africanum associated with involvement of the upper and lower respiratory tract, skin, and mucosa.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):653-5.
1995: F Doucet-Populaire; C Truffot-Pernot; Jacques H Grosset; Vincent Jarlier
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
The Journal of antimicrobial chemotherapy 1995;36(1):129-36.
1995: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(6):1341-4.
1995: Jacques H Grosset; Y Mouton
Is PCR a useful tool for the diagnosis of tuberculosis in 1995?
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1995;76(3):183-4.
1995: L Struillou; Y Cohen; N Lounis; G Bertrand; Jacques H Grosset; J L Vildé; J J Pocidalo; Christian Perronne
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice.
Antimicrobial agents and chemotherapy 1995;39(4):878-81.
1995: Y Cohen; Christian Perronne; T Lazard; C Truffot-Pernot; Jacques H Grosset; J L Vilde; J J Pocidalo
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.
Antimicrobial agents and chemotherapy 1995;39(3):735-8.
1995: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
Antimicrobial agents and chemotherapy 1995;39(3):608-12.
1994: Emmanuelle Cambau; Wladimir Sougakoff; M Besson; Chantal Truffot-Pernot; Jacques H Grosset; Vincent Jarlier
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(5):1351.
1994: L Chapuis; Baohong Ji; Chantal Truffot-Pernot; R J O'Brien; M C Raviglione; Jacques H Grosset
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.
American journal of respiratory and critical care medicine 1994;150(5 Pt 1):1355-62.
1994: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model.
Antimicrobial agents and chemotherapy 1994;38(11):2521-9.
1994: Emmanuelle Cambau; Wladimir Sougakoff; M Besson; Chantal Truffot-Pernot; Jacques H Grosset; Vincent Jarlier
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(2):479-83.
1994: T Lazard; Christian Perronne; C Truffot-Pernot; Jacques H Grosset; J L Vildé; J J Pocidalo
Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophages.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(4):283-5.
1994: B Heym; Nadine Honoré; Chantal Truffot-Pernot; A Banerjee; Catherine Schurra; William R. Jacobs Jr.; Jan D A Van Embden; Jacques H Grosset; Stewart T Cole
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.
Lancet 1994;344(8918):293-8.
1994: Jacques H Grosset
Progress in the chemotherapy of leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1994;62(2):268-77.
1994: Jacques H Grosset
Assessment of new therapies for infection due to the Mycobacterium avium complex: appropriate use of in vitro and in vivo testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18 Suppl 3():S233-6.
1994: Baohong Ji; Evelyne Perani; C Petinom; L N'Deli; Jacques H Grosset
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Antimicrobial agents and chemotherapy 1994;38(4):662-7.
1994: J H Xiong; Baohong Ji; Evelyne Perani; C Pétinon; Jacques H Grosset
Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1994;62(1):37-42.
1994: V Schwoebel; Bruno Hubert; Jacques H Grosset
Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccination.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(1):44-8.
1994: B P Vareldzis; Jacques H Grosset; Isabel N de Kantor; J Crofton; A Laszlo; M Felten; Mario C Raviglione; Arata Kochi
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(1):1-7.
1993: Baohong Ji; Chantal Truffot-Pernot; C Lacroix; M C Raviglione; R J O'Brien; P Olliaro; G Roscigno; Jacques H Grosset
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
The American review of respiratory disease 1993;148(6 Pt 1):1541-6.
1993: Nadine Honoré; E Perrani; A Telenti; Jacques H Grosset; Stewart T Cole
A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1993;61(4):600-4.
1993: Gilles Hejblum; V Jarlier; Jacques H Grosset; André Aurengo
Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm.
Journal of clinical microbiology 1993;31(9):2396-401.
1993: T Lazard; Christian Perronne; Jacques H Grosset; J L Vilde; J J Pocidalo
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
Antimicrobial agents and chemotherapy 1993;37(8):1690-2.
1993: Baohong Ji; P Jamet; Evelyne Perani; P Bobin; Jacques H Grosset
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
The Journal of infectious diseases 1993;168(1):188-90.
1993: Philippe Glaziou; J L Cartel; J P Moulia-Pelat; L N Ngoc; Suzanne Chanteau; R Plichart; Jacques H Grosset
Tuberculosis in leprosy patients detected between 1902 and 1991 in French Polynesia.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1993;61(2):199-204.
1993: T Lazard; Christian Perronne; Y Cohen; Jacques H Grosset; J L Vilde; J J Pocidalo
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.
Antimicrobial agents and chemotherapy 1993;37(4):692-5.
1993: V Lalande; Chantal Truffot-Pernot; A Paccaly-Moulin; Jacques H Grosset; Baohong Ji
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 1993;37(3):407-13.
1993: Bertrand Dautzenberg; T Saint Marc; M C Meyohas; M Eliaszewitch; F Haniez; A M Rogues; S De Wit; L Cotte; J P Chauvin; Jacques H Grosset
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Archives of internal medicine 1993;153(3):368-72.
1992: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy.
Antimicrobial agents and chemotherapy 1992;36(12):2839-40.
1992: Baohong Ji; Evelyne Perani; C Petinon; Jacques H Grosset
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1992;60(4):556-61.
1992: Jacques H Grosset
Treatment of tuberculosis in HIV infection.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1992;73(6):378-83.
1992: Christian Perronne; Y Cohen; C Truffot-Pernot; Jacques H Grosset; J L Vildé; J J Pocidalo
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.
Antimicrobial agents and chemotherapy 1992;36(11):2408-12.
1992: Jean-Jacques Rouby; E Martin De Lassale; P Poete; M H Nicolas; L Bodin; Vincent Jarlier; Y Le Charpentier; Jacques H Grosset; P Viars
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects.
The American review of respiratory disease 1992;146(4):1059-66.
1992: Y Cohen; Christian Perronne; C Truffot-Pernot; Jacques H Grosset; J L Vilde; J J Pocidalo
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.
Antimicrobial agents and chemotherapy 1992;36(10):2104-7.
1992: Louis-Jean Couderc; Bernard Epardeau; M C Dazza; jean-pierre emile clauvel; B Autran; Jacques H Grosset; I Caubarrere
Disseminated Mycobacterium avium intracellulare infection without predisposing conditions.
Lancet 1992;340(8821):731.
1992: V Schwoebel; Bruno Hubert; Jacques H Grosset
Impact of BCG on tuberculous meningitis in France in 1990.
Lancet 1992;340(8819):611.
1992: J L Cartel; Suzanne Chanteau; J P Moulia-Pelat; R Plichart; Philippe Glaziou; Jean-Paul Boutin; J F Roux; Jacques H Grosset
Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1992;60(3):416-20.
1992: J L Cartel; André Spiegel; L Nguyen Ngoc; J P Moulia-Pelat; P M Martin; Jacques H Grosset
Leprosy in French Polynesia. The possible impact of multidrug therapy on epidemiological trends.
Leprosy review 1992;63(3):223-30.
1992: J L Cartel; Jean-Paul Boutin; André Spiegel; Philippe Glaziou; R Plichart; R Cardines; Jacques H Grosset
Leprosy in French Polynesia. Epidemiological trends between 1946 and 1987.
Leprosy review 1992;63(3):211-22.
1992: S Pretet; LeBeaut Pierre Alexandre; R Parrot; C Truffot; Jacques H Grosset; Anh Tuan Dinh-Xuan
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection).
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(6):680-4.
1992: Jacques H Grosset; Chantal Truffot-Pernot; C Lacroix; Baohong Ji
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Antimicrobial agents and chemotherapy 1992;36(3):548-51.
1991: Bertrand Dautzenberg; C Truffot; S Legris; M C Meyohas; H C Berlie; A Mercat; S Chevret; Jacques H Grosset
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
The American review of respiratory disease 1991;144(3 Pt 1):564-9.
1991: Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.
Tubercle 1991;72(3):181-6.
1991: Bertrand Dautzenberg; C Truffot; A Mignon; W Rozenbaum; C Katlama; C Perronne; R Parrot; Jacques H Grosset
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Tubercle 1991;72(3):168-75.
1991: Chantal Truffot-Pernot; Baohong Ji; Jacques H Grosset
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.
Antimicrobial agents and chemotherapy 1991;35(8):1677-8.
1991: Christian Perronne; A Gikas; C Truffot-Pernot; Jacques H Grosset; J L Vilde; J J Pocidalo
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Antimicrobial agents and chemotherapy 1991;35(7):1356-9.
1991: M Constant-Desportes; C C Guelpa-Lauras; J C Carolina; A Léoture; Jacques H Grosset; H Sansarricq
A case of relapse with drug-susceptible M. leprae after multidrug therapy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1991;59(2):242-7.
1991: Chantal Truffot-Pernot; Baohong Ji; Jacques H Grosset
Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.
Tubercle 1991;72(1):57-64.
1991: Baohong Ji; Evelyne Perani; Jacques H Grosset
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Antimicrobial agents and chemotherapy 1991;35(3):579-81.
1991: Baohong Ji; Jacques H Grosset
Ofloxacin for the treatment of leprosy.
Acta leprologica 1991;7(4):321-6.
1990: Suzanne Chanteau; J L Cartel; Evelyne Perani; L N'Deli; J Roux; Jacques H Grosset
Relationships between PGL-1 antigen in serum, tissue and viability of Mycobacterium leprae as determined by mouse footpad assay in multibacillary patients during short-term clinical trial.
Leprosy review 1990;61(4):330-40.
1990: Baohong Ji; Jacques H Grosset
Recent advances in the chemotherapy of leprosy.
Leprosy review 1990;61(4):313-29.
1990: Jacques H Grosset
[Norfloxacin: a broad-spectrum quinolone for superficial eye infections].
Pathologie-biologie 1990;38(7):735-41.
1990: J L Cartel; Suzanne Chanteau; Jean-Paul Boutin; R Plichart; P Richez; J F Roux; Jacques H Grosset
Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(3):512-7.
1990: Christian Perronne; A Gikas; C Truffot-Pernot; Jacques H Grosset; J J Pocidalo; J L Vilde
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Antimicrobial agents and chemotherapy 1990;34(8):1508-11.
1990: L Abel; V V Cua; J Oberti; V D Lap; L K Due; Jacques H Grosset; P H Lagrange
Leprosy and BCG in southern Vietnam.
Lancet 1990;335(8704):1536.
1990: Jacques H Grosset
Present and new drug regimens in chemotherapy and chemoprophylaxis of tuberculosis.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;65(2-3):86-91.
1990: Jacques H Grosset; H Boisvert; C Truffot-Pernot; C Rica
Organization of laboratory services in low prevalence countries, our personal view.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;65(2-3):60-3.
1990: Jacques H Grosset; B H Ji; C C Guelpa-Lauras; Evelyne Perani; L N N'Deli
Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(2):281-95.
1990: Jacques H Grosset
[Bacteriologic basis for the treatment of tuberculosis].
La Revue du praticien 1990;40(8):715-8.
1990: L N'Deli; C C Guelpa-Lauras; Evelyne Perani; Jacques H Grosset
Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1990;58(1):12-8.
1990: Jacques H Grosset
New experimental regimens for preventive therapy of tuberculosis.
Bulletin of the International Union against Tuberculosis and Lung Disease 1990;66 Suppl():15-6.
1989: J L Cartel; Suzanne Chanteau; Jean-Paul Boutin; R Taylor; R Plichart; J Roux; P Celerier; Jacques H Grosset
Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(4):810-6.
1989: H F Lecoeur; Chantal Truffot-Pernot; Jacques H Grosset
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
The American review of respiratory disease 1989;140(5):1189-93.
1989: Jean-Jacques Rouby; M D Rossignon; M H Nicolas; E Martin de Lassale; S Cristin; Jacques H Grosset; P Viars
A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia.
Anesthesiology 1989;71(5):679-85.
1989: Chantal Truffot-Pernot; H F Lecoeur; L Maury; Bertrand Dautzenberg; Jacques H Grosset
Results of blood cultures for detection of mycobacteria in AIDS patients.
Tubercle 1989;70(3):187-91.
1989: Jacques H Grosset; C C Guelpa-Lauras; P Bobin; G Brucker; J L Cartel; M Constant-Desportes; B Flageul; M Frédéric; J C Guillaume; J Millan
Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(3):607-14.
1989: Vincent Jarlier; M H Nicolas; A Philippon; A M Giroir; Jacques H Grosset
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
The Journal of antimicrobial chemotherapy 1989;24(2):165-72.
1989: Jacques H Grosset; J Baohang; S K Noordeen
Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Indian journal of leprosy 1989;61(3):323-7.
1989: Jacques H Grosset; B H Ji
Controlled clinical trial for evaluation of antimicrobial drug activity against M. leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1989;57(2):529-31.
1989: H F Lecoeur; P H Lagrange; Chantal Truffot-Pernot; M Gheorghiu; Jacques H Grosset
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
Clinical and experimental immunology 1989;76(3):458-62.
1989: Jacques H Grosset
Present status of chemotherapy for tuberculosis.
Reviews of infectious diseases 1989;11 Suppl 2():S347-52.
1988: D A Mitchison; G A Ellard; Jacques H Grosset
New antibacterial drugs for the treatment of mycobacterial disease in man.
British medical bulletin 1988;44(3):757-74.
1988: Jacques H Grosset; Chantal Truffot-Pernot; H Lecoeur
[New and future drugs in pulmonary tuberculosis].
Praxis und Klinik der Pneumologie 1988;42 Suppl 1():206-10.
1988: Jacques H Grosset; C C Guelpa-Lauras; Evelyne Perani; C Beoletto
Activity of ofloxacin against Mycobacterium leprae in the mouse.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1988;56(2):259-64.
1988: R G Parrot; Jacques H Grosset
Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection.
Tubercle 1988;69(1):47-55.
1988: C Lepetit; A Thebaud-Mony; Jacques H Grosset
[Tuberculosis in the Department of Seine-Saint Denis. I. Cases under treatment in 1984].
Revue des maladies respiratoires 1988;5(2):129-36.
1988: J L Cartel; Jean-Paul Boutin; R Plichart; J Roux; Jacques H Grosset
[Leprosy in the French Polynesian archipelagoes from 1967 to 1987].
Bulletin de la Société de pathologie exotique et de ses filiales 1988;81(5):819-26.
1988: B Dautzenberg; Jacques H Grosset
[Tuberculosis and pregnancy].
Revue des maladies respiratoires 1988;5(3):279-83.
1988: Chantal Truffot-Pernot; A M Giroir; L Maury; Jacques H Grosset
[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Revue des maladies respiratoires 1988;5(4):401-6.
1987: Jacques H Grosset; C C Guelpa-Lauras
Activity of rifampin in infections of normal mice with Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):847-51.
1987: J L Cartel; Y Naudillon; J C Remy; Jacques H Grosset
Contribution of relapses to total infection sources of leprosy in Guadeloupe.
Leprosy review 1987;58(4):339-48.
1987: R D McDermott-Lancaster; T Ito; K Kohsaka; C C Guelpa-Lauras; Jacques H Grosset
Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):889-95.
1987: Jacques H Grosset
Pharmacokinetics in drug screening.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):852-6.
1987: Jacques H Grosset; J Baohong; T Ito
The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(4 Suppl):807-13.
1987: Catherine Mouquet; J Fusciardi; M P Stoupak; G Vallancien; Vincent Jarlier; C Chatelain; Jacques H Grosset; P Viars
[Transurethral surgery and persistent urinary infection: effect of a single preoperative dose of cefuroxime].
Pathologie-biologie 1987;35(9):1243-7.
1987: Jacques H Grosset; H Lecoeur
[Present status of vaccination against leprosy].
Acta leprologica 1987;5(3):231-9.
1987: Jacques H Grosset; C C Guelpa-Lauras; J Millan; M Bodian; Evelyne Perani
[Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Médecine tropicale : revue du Corps de santé colonial 1987;47(2):171-5.
1987: C C Guelpa-Lauras; Evelyne Perani; A M Giroir; Jacques H Grosset
Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1987;55(1):70-7.
1987: Jacques H Grosset; V Jarlier; H Lecoeur
[BCG vaccination in France].
Revue des maladies respiratoires 1987;4(2):69-74.
1986: Vincent Jarlier; Claude-James Soussy; M Chanal; Danielle Sirot; J Le Van Thoi; R Bismuth; Jacques H Grosset; J Duval; R Cluzel
[In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics].
Presse médicale (Paris, France : 1983) 1986;15(46):2272-8.
1986: Bertrand Dautzenberg; C Gallinari; G Aeberhardt; A Lévy; J Bernheim; Jacques H Grosset; C Sors
[Routine use of 6-month antitubercular treatment in 300 patients].
Presse médicale (Paris, France : 1983) 1986;15(43):2151-2, 2157-8.
1986: J Millan; G Roux; S Loko; J C Naudin; P Boucher; M Bodian; M Camara; T Moreira-Diop; Jacques H Grosset
[Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Acta leprologica 1986;4(4):427-44.
1986: J C Cartel; J J Gallais; Y Naudillon; J Millan; Jacques H Grosset
[5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Acta leprologica 1986;4(4):415-25.
1986: G Soga; L Blanc; C Alfa; Jacques H Grosset; S Xavier
[Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
Acta leprologica 1986;4(4):397-407.
1986: M Constant-Desportes-Relouzat; Jacques H Grosset; C C Guelpalauras; B Salvini; D Cales-Quist
[Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
Acta leprologica 1986;4(3):293-300.
1986: Jacques H Grosset; H Lecoeur
[Vaccination against leprosy].
Acta leprologica 1986;4(3):289-91.
1986: J L Cartel; J J Gallais; Y Naudillon; J G Rémy; Jacques H Grosset
[Epidemiology of leprosy in Guadeloupe from 1970 to 1984].
Acta leprologica 1986;4(2):161-73.
1986: A Sébille; M O Crepon; C C Guelpa; Jacques H Grosset
[Electrophysiologic demonstration of the activity of rifampicin on nerve disease developing in mice inoculated with Hansen's bacilli in the footpad].
Acta leprologica 1986;4(2):215.
1986: Dominique Choudat; P Horreard; S Pretet; Jacques H Grosset; L Toty
Superinfection by Aspergillus fumigatus of a pulmonary lesion caused by Mycobacterium xenopi.
Tubercle 1986;67(1):71-4.
1986: Jacques H Grosset
Recent developments in the field of multidrug therapy and future research in chemotherapy of leprosy.
Leprosy review 1986;57 Suppl 3():223-34.
1986: J Millan; M Bodian; J C Naudin; B Diouf; P Boucher; B Ndoye; Jacques H Grosset
[A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
Acta leprologica 1986;4(1):19-35.
1985: J L Cartel; J J Gallais; Jacques H Grosset
[Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
Acta leprologica 1985;3(4):339-55.
1985: C Sors; E Bouvet; Jacques H Grosset; S Perdrizet; S Pretet
[Aspects of tuberculosis in France].
Revue de l'infirmière 1985;35(15):29-34.
1985: A Sebille; M O Crepon; C C Guelpa; Jacques H Grosset
Evidence for the activity of rifampin on the neuropathy of foot pad-inoculated mice with Mycobacterium leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(3):481-3.
1985: M Nebout; Jacques H Grosset
[Present-day difficulties in the campaign against leprosy and proposals for its resumption in French-speaking Africa].
Acta leprologica 1985;3(3):233-7.
1985: J L Cartel; Y Naudillon; J C Artus; Jacques H Grosset
[Epidemiology of leprosy in Guadalupe between 1970 and 1983].
Boletín de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 1985;98(6):535-47.
1985: Jacques H Grosset
Mechanisms of action of antituberculosis drugs in standard and short-course chemotherapy regimens.
Revista de igienă, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia 1985;34(2):108-15.
1985: Jacques H Grosset
Bacteriological bases of short-course chemotherapy.
Revista de igienă, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia 1985;34(2):103-7.
1985: J L Cartel; Y Naudillon; J C Artus; Jacques H Grosset
Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(1):15-8.
1985: Jacques H Grosset; L Levy; R J Rees; C C Shepard
Drug sensitivity testing of M. leprae.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1985;53(1):118-21.
1985: Jacques H Grosset; Chantal Truffot-Pernot; S Poggi; H Lecoeur; C Chastang
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
Revue des maladies respiratoires 1985;2(4):205-8.
1984: Vincent Jarlier; R Bismuth; M H Nicolas; J Nguyen; C Truffot; Jacques H Grosset
Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.
The Journal of antimicrobial chemotherapy 1984;14 Suppl B():59-65.
1984: V Jarlier; C Truffot-Pernot; Jacques H Grosset
[Potential value of the amoxicillin-clavulanic acid combination in general medicine, gynecology-obstetrics and pediatrics departments].
Pathologie-biologie 1984;32(5 Pt 2):492-5.
1984: C C Guelpa-Lauras; Jacques H Grosset; M Constant-Desportes; G Brucker
Nine cases of rifampin-resistant leprosy.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1984;52(1):101-2.
1984: Bertrand Dautzenberg; Jacques H Grosset; J Fechner; J Lucciani; P Debre; S Herson; C Truffot; C Sors
The management of thirty immunocompromised patients with tuberculosis.
The American review of respiratory disease 1984;129(3):494-6.
1984: Jacques H Grosset; C Sors
[Mycobacterioses].
Presse médicale (Paris, France : 1983) 1984;13(4):215-8.
1984: H Giroulle; L Bernabeu; H Boisvert; C Truffot; Jacques H Grosset
[Pulmonary mycobacteriosis due to a non-chromogenic, slow-growing, unclassified mycobacterium].
Revue des maladies respiratoires 1984;1(3):161-4.
1984: Jacques H Grosset
[Advances in the chemotherapy of leprosy].
Médecine tropicale : revue du Corps de santé colonial 1984;44(1):17-22.
1983: J L Cartel; J Millan; C C Guelpa-Lauras; Jacques H Grosset
Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 1983;51(4):461-5.
1983: Jacques H Grosset; S Leventis
Adverse effects of rifampin.
Reviews of infectious diseases 1983;5 Suppl 3():S440-50.
1983: Jacques H Grosset; C Truffot-Pernot; R Bismuth; H Lecoeur
[Recent data on the chemotherapy of experimental tuberculosis in the mouse].
Bulletin of the International Union against Tuberculosis 1983;58(2):90-6.
1983: Jacques H Grosset; Chantal Truffot-Pernot; H Lecoeur; C C Guelpa-Lauras
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice].
Pathologie-biologie 1983;31(5):446-50.
1983: R Bismuth; Vincent Jarlier; Jacques H Grosset
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
Pathologie-biologie 1983;31(5):429-33.
1983: Vincent Jarlier; R Bismuth; Jacques H Grosset
[Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Pathologie-biologie 1983;31(5):336-42.
1983: Chantal Truffot-Pernot; Jacques H Grosset; R Bismuth; H Lecoeur
[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
Revue française des maladies respiratoires 1983;11(6):875-82.
1983: R Parrot; C Boval; Jacques H Grosset; J P Gaillard
[Adjusting or not adjusting isoniazid dosage?].
Revue française des maladies respiratoires 1983;11(5):705-12.
1983: J Cooreman; G Burghard; Jacques H Grosset
[Resistance of the Koch bacillus to antibacillary agents in the Department of the Lower Rhine].
Revue française des maladies respiratoires 1983;11(5):699-704.
1982: Jacques H Grosset; C Truffot-Pernot
[Laboratories: their role in the diagnosis and treatment of tuberculosis].
Bulletin of the International Union against Tuberculosis 1982;57(3-4):234-41.
1982: Jacques H Grosset; C Truffot; J Fermanian; H Lecoeur
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
Pathologie-biologie 1982;30(6):444-8.
1982: C Sors; Bertrand Dautzenberg; Jacques H Grosset
[Duration of the treatment of tuberculosis in 1981].
La Nouvelle presse médicale 1982;11(11):831.
1982: Jacques H Grosset; C Truffot; C Boval
The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis.
Tubercle 1982;63(1):37-43.
1982: Jacques H Grosset; C Truffot-Pernot
[Biology of the tubercle bacillus].
Revue médicale de la Suisse romande 1982;102(3):257-63.
1982: Jacques H Grosset; R Bismuth; J Nguyen
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)].
Revue française des maladies respiratoires 1982;10(3):195-203.
1982: J Nguyen; Bertrand Dautzenberg; Jacques H Grosset; C Sors
[Results of antibiotic sensitivity and "Streptococcus pneumoniae" serotype tests in the Pitié-Salpêtrière hospital, France, 1979-1980 (author's transl)].
Revue française des maladies respiratoires 1982;10(2):115-20.
1982: C C Guelpa-Lauras; M Constant-Desportes; J Millan; Jacques H Grosset
[Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Acta leprologica 1982;(86-87):77-80.
1982: C C Guelpa-Lauras; Jacques H Grosset; C Truffot-Pernot; A M Giroir
[Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae].
Acta leprologica 1982;(86-87):69-75.
1982: Jacques H Grosset; C C Guelpa-Lauras; H Lecoeur
[Current data on the bacteriology of leprosy].
Acta leprologica 1982;(86-87):35-45.
1981: Jacques H Grosset
Studies in short-course chemotherapy for tuberculosis. Basis for short-course chemotherapy.
Chest 1981;80(6):719-20.
1980: Jacques H Grosset
Bacteriologic basis of short-course chemotherapy for tuberculosis.
Clinics in chest medicine 1980;1(2):231-41.
1980: Jacques H Grosset
The efficacy of short-course chemotherapy for tuberculosis.
Bulletin of the Pan American Health Organization 1980;14(2):139-49.
1979: Jacques H Grosset
[The bacteriological principles of tuberculosis treatments].
La Revue du praticien 1979;29(33):2645-50.
1979: B Dautzenberg; J Nguyen; Jacques H Grosset; C Sors
[A comparative study of three procedures used for studying bronchopulmonary bacterial flora (author's transl)].
Annales de médecine interne 1979;130(8-9):415-8.
1978: S Pretet; Jacques H Grosset; S Perdrizet
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Bulletin of the International Union against Tuberculosis 1978;53(4):260-1.
1978: Jacques H Grosset
[Short term chemotherapy of tuberculosis. Current experimental findings in short term chemotherapy].
Bulletin of the International Union against Tuberculosis 1978;53(4):281-3.
1978: Jacques H Grosset
The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy.
Bulletin of the International Union against Tuberculosis 1978;53(1):5-12.
1976: Jacques H Grosset; P Glaser; A Baud; R Bismuth
[Bacterial flora in pneumopathies and its significance in surgical resuscitation].
Lille médical : journal de la Faculté de médecine et de pharmacie de l'Université de Lille 1976;21(2):97-9.
1973: M Vayssairat; R Moulias; P Rameix; Jacques H Grosset; G Chomette; J Loeper
[Two new cases of pulmonary mycobacteriosis due to Mycobacterium xenopi].
Annales de médecine interne 1973;124(4):309-12.
1972: G Canetti; M Le Lirzin; P Gay; R Thibier; B Kreis; Jacques H Grosset
[Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
Revue de tuberculose et de pneumologie 1972;36(3):337-56.
1971: Jacques H Grosset
Georges Canetti (1911-1971).
Bulletin of the International Union against Tuberculosis 1971;46():7-8.
1971: Jacques H Grosset; G Decroix; C Sors
[Tuberculosis due to Mycobacterium africanum in African negroes in the Paris area].
Revue de tuberculose et de pneumologie 1971;35(4):430-6.
1971: F Boulahbal; Jacques H Grosset
[Use of pyridinium cetyl bromide as a transport medium for tuberculous sputum. Preliminary study].
Archives de l'Institut Pasteur d'Algérie Institut Pasteur d'Algérie 1971;49():51-9.
1970: D Larbaoui; P Chaulet; Jacques H Grosset; K Abderrahim; H Ait-Mesbah
The efficiency of methods of diagnosing pulmonary tuberculosis: an investigation in a chest clinic in Algiers.
Tubercle 1970;51(4):403-11.
1970: D Larbaoui; P Chaulet; Jacques H Grosset; K Abderrahim; A Zirout
[Controlled study of a bi-weekly treatment with isoniazid and ethionamide].
Bulletin of the International Union against Tuberculosis 1970;43():282-8.
1970: G Canetti; Jacques H Grosset; M Le Lirzin
[Sterilization of tuberculous lesions under chemotherapy in humans. Main report].
Bulletin of the International Union against Tuberculosis 1970;43():347-59.
1970: D Larbaoui; P Chaulet; Jacques H Grosset; K Abderrahim; N Oussedik; C Coucke; L Benabdallah
[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
Revue de tuberculose et de pneumologie 1970;34(4):559-66.
1970: O de Beco; F Boulahbal; Jacques H Grosset
[Incidence of the bovine bacillus in human tuberculosis at Algiers in 1969].
Archives de l'Institut Pasteur d'Algérie Institut Pasteur d'Algérie 1970;48():93-101.
1970: Jacques H Grosset; M Benhassine
[Thiacetazone (Tb-1): recent experimental and clinical data].
Bibliotheca tuberculosea 1970;26():107-53.
1968: Jacques H Grosset; K Abderrahim; P Chaulet; D Larbaoui
[Results of bi-weekly treatment with isoniazid and streptomycine in 135 cases of pulmonary tuberculisis, in Algiers].
Bulletin of the International Union against Tuberculosis 1968;41():325-30.
1968: Jacques H Grosset; M Benhassine; L Mokhtari
[Trial B.C.G. vaccination without previous tuberculin test in an Algiers outpatient clinic].
Revue de tuberculose et de pneumologie 1968;32(4):551-60.
1968: P Chaulet; M Boulahbal; Jacques H Grosset
[Acquired resistance to antibiotics of the tuberculosis bacillus in the Algiers area from 1963 to 1967. Importance and epidemiologic significance].
Revue de tuberculose et de pneumologie 1968;32(4):542-51.
1968: J Seror; Jacques H Grosset
[Apropos of a case of mesenteric adenitis caused by Eberth's bacillus].
Annales de chirurgie 1968;22(9):629-31.
1968: P Chaulet; K Abderrahim; Jacques H Grosset; D Larbaoui
Clinical experience in Algeria of intermittent treatment of pulmonary tuberculosis with isoniazid and streptomycin twice-weekly.
Tubercle 1968;49():Suppl:81-2.
1968: Jacques H Grosset; F Rodrigues; M Benhassine; P Chaulet; D Larbaoui
Sensitivity to thiacetazone of strains of Mycobacterium tuberculosis isolated in Algiers: practical deductions.
Tubercle 1968;49():Suppl:46-8.
1967: P Chaulet; D Larbaoui; Jacques H Grosset; K Abderrahim
Intermittent chemotherapy with isoniazid and streptomycin in Algiers.
Tubercle 1967;48(2):128-36.
1967: Jacques H Grosset; M Benhassine
[Antibiotic primary resistance of mycobacterium tuberculosis in hospitals in Algeria (1964-1966)].
Revue de tuberculose et de pneumologie 1967;31(4):475-90.
1967: F Grumbach; G Canetti; Jacques H Grosset; M le Lirzin
Late results of long-term intermittent chemotherapy of advanced, murine tuberculosis: limits of the murine model.
Tubercle 1967;48(1):11-26.
1964: G CANETTI; B KREIS; R THIBIER; Jacques H Grosset; J GLUSZYK
[INCIDENCE AND CHARACTERISTICS OF PRIMARY RESISTANCE IN 2144 CASES OF UNTREATED PULMONARY TUBERCULOSIS FROM DIFFERENT REGIONS OF FRANCE. (PRELIMINARY REPORT OF THE CENTRE D'ETUDE SUR LA R'ESISTANCE PRIMAIRE)].
Revue de tuberculose et de pneumologie 1964;28():1115-58.
1964: G CANETTI; N RIST; Jacques H Grosset
PRIMARY DRUG RESISTANCE IN TUBERCULOSIS.
The American review of respiratory disease 1964;90():792-9.
1964: F GRUMBACH; G CANETTI; Jacques H Grosset
FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.
Tubercle 1964;45():125-35.
1963: J N VIVIEN; R THIBIER; A LEPEUPLE; G CANETTI; Jacques H Grosset
[SYSTEMATIC DETERMINATION OF ACTIVE ISONIAZID IN THE BLOOD SERUM. (DATA FROM A SERIES OF 1,000 PATIENTS)].
Revue de tuberculose et de pneumologie 1963;27():1103-18.
1963: G CANETTI; F GRUMBACH; Jacques H Grosset
Long-term, two-stage chemotherapy of advanced experimental murine tuberculosis with intermittent regimes during the second stage.
Tubercle 1963;44():236-40.
1963: R THIBIER; A LEPEUPLE; J N VIVIEN; Jacques H Grosset
[RESULTS OF CHEMOTHERAPY AMONG 221 PATIENTS WITH PULMONARY TUBERCULOSIS DUE TO BACILLI INITIALLY SENSITIVE TO PRINCIPAL ANTIBIOTICS (FOLLOW UP OF 2 TO 5 YEARS)].
Revue de tuberculose et de pneumologie 1963;27():541-50.
1963: G CANETTI; N RIST; Jacques H Grosset
[Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].
Revue de tuberculose et de pneumologie 1963;27():217-72.
1963: G CANETTI; S FROMAN; Jacques H Grosset; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.
Bulletin of the World Health Organization 1963;29():565-78.
1963: A LEPEUPLE; R THIBIER; J N VIVIEN; G CANETTI; Jacques H Grosset
[Identification of the sources of contagion in various cases of primary tuberculosis resistance].
Revue de tuberculose et de pneumologie 1963;27():53-66.
1962: J N VIVIEN; R THIBIER; A LEPEUPLE; Jacques H Grosset
[The exactness of the practical measurement of active serum isoniazid levels by the vertical diffusion microbiological method].
Revue de tuberculose et de pneumologie 1962;26():978-88.
1962: Jacques H Grosset; G CANETTI
[Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
Annales de l'Institut Pasteur 1962;103():163-84.
1962: R THIBIER; G CANETTI; A LEPEUPLE; Jacques H Grosset; J N VIVIEN
[Tuberculosis caused by primary-resistant bacilli in university students during the years 1958-1960].
Bulletin of the International Union against Tuberculosis 1962;32():113-7.
1961: Jacques H Grosset; G CANETTI
[Differences in the number of streptomycin-resistant variants in strains of Mycobacterium tuberculosis according to the type of streptomycin and the culture medium used].
Annales de l'Institut Pasteur 1961;101():234-52.
1961: G CANETTI; Jacques H Grosset
[Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium].
Annales de l'Institut Pasteur 1961;101():28-46.
1961: J N VIVIEN; Jacques H Grosset
[The level of active isoniazid in the blood serum].
Bibliotheca tuberculosea 1961;16():45-121.
1960: A LEPEUPLE; R THIBIER; J N VIVIEN; Jacques H Grosset; G CANETTI
[A case of transmission of Koch bacilli from a tuberculous subject to a subject recovered from pulmonary tuberculosis].
Rivista di chirurgia pediatrica 1960;24():1312-21.
1960: G CANETTI; F GRUMBACH; Jacques H Grosset
Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid.
The American review of respiratory disease 1960;82():295-313.
1960: R THIBIER; G CANETTI; A LEPEUPLE; Jacques H Grosset; J N VIVIEN
[Pulmonary tuberculosis with resistant bacilli in patients not yet treated].
Revue de tuberculose et de pneumologie 1960;24():831-68.
1960: F GRUMBACH; Jacques H Grosset; G CANETTI
[The inactivation of isoniazid in the rat. Its effects on the results of the chemotherapy of tuberculosis in that species].
Annales de l'Institut Pasteur 1960;98():642-56.
1960: Jacques H Grosset; G CANETTI
[Complementary data on the determination of active isoniazid of the blood serum by the method of vertical diffusion. Determination in presence of PAS].
Revue de tuberculose et de pneumologie 1960;24():633-47.
1958: G CANETTI; J BRETEY; A SAENZ; Jacques H Grosset
[Effect of early treatment with isoniazid on the immunity induced in guinea pigs by a small dose of standard BCG; further data on the immunizing capacity of isoniazid-resistant BCG].
Annales de l'Institut Pasteur 1958;95(3):262-71.
1958: G CANETTI; Jacques H Grosset
[Frequency of post-primary bronchial gland fistulas in 397 cases of pulmonary tuberculosis in adults treated by exeresis; discussion of their phthisiogenic role].
Revue de la tuberculose 1958;22(7):653-7.
1958: J N VIVIEN; R THIBIER; Jacques H Grosset; A LEPEUPLE
[Early results of isoniazid therapy as a function of the active blood level of isoniazid; study of 100 cases].
Revue de la tuberculose 1958;22(2-3):208-22.
1958: Jacques H Grosset; G CANETTI; R THIBIER; J N VIVIEN; J LEPEUPLE; A SAENZ
[Comparative effects of oral and intravenous p-aminosalicylic acid on the active blood level of isoniazid].
Revue de la tuberculose 1958;22(2-3):202-7.
1957: Jacques H Grosset; F GRUMBACH; G CANETTI
[Modification of methods of biological measurement of isoniazid in blood serum; results in 53 cases].
Annales de l'Institut Pasteur 1957;92(6):752-9.
1956: G CANETTI; Jacques H Grosset
[Late positivization of cultures of tuberculosis bacilli; its relation to isoniazid resistance].
Revue de la tuberculose 1956;20(11-12):1053-61.